Healthcare challenges for elderly people in Japan during COVID-19 pandemic
The health impact for elderly people in Japan under COVID-19 and its response
The impact of COVID-19 oThe impact of COVID-19 on the Japanese elderly people and the challenges to the crises are described.n the Japanese health care industry and the response to the crises by the government of Japan are described.
Under the spotlight
Data integrity in life sciences
Regulatory bodies now have high expectations with regard to data quality and integrity owing to the life sciences industry’s growth, globalization and adoption of advanced technology, such as highly automated systems and storage of data in ‘The Cloud’. Read the report to learn more.
Identification of Medicinal Products
Identification of Medicinal Products (IDMP) is one the biggest regulatory challenges for all pharmaceutical companies operating in Europe. How can your organisation navigate this journey towards increased patient safety and use it as an opportunity for business transformation?
High-value health care
Innovative approaches to global challenges
What are pioneering health care providers, health plans, and life science companies doing to anticipate patient needs, reduce costs, and improve overall health outcomes in the US and globally? Learn more in this new Deloitte Center for Health Solutions research.